Coherus Oncology, Inc. Increase (Decrease) in Prepaid Expense
Coherus Oncology, Inc. (CHRS) reported Increase (Decrease) in Prepaid Expense of -$4.49 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-05-11
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was -$4.49M.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$1.29M, a 240.52% decline year-over-year.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $1.35M, a 15.11% decline year-over-year.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-06-30 was -$208.00K, a 108.60% decline year-over-year.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for fiscal 2025 was -$338.00K.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$4.66M.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $4.21M.
- Coherus Oncology, Inc. increase (decrease) in prepaid expense for fiscal 2021 was -$3.83M, a 135.28% decline from fiscal 2020.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$4.49M 10-Q · filed 2026-05-11 | -$5.78M derived: sum of 2 quarters · filed 2026-05-11 | -$4.43M derived: sum of 3 quarters · filed 2026-05-11 | -$4.63M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2025-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $58.00K derived: sum of 2 quarters · filed 2026-03-09 | -$150.00K derived: sum of 3 quarters · filed 2026-03-09 | -$338.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.14M derived: sum of 2 quarters · filed 2025-11-06 | $952.00K 10-Q · filed 2025-11-06 | $1.87M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2025-06-30 | -$208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$396.00K 10-Q · filed 2025-08-07 | $522.00K derived: sum of 3 quarters · filed 2026-05-11 | $2.11M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2025-03-31 | -$188.00K 10-Q · filed 2026-05-11 | $730.00K derived: sum of 2 quarters · filed 2026-05-11 | $2.32M derived: sum of 3 quarters · filed 2026-05-11 | $4.74M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $918.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.51M derived: sum of 2 quarters · filed 2026-03-09 | $4.92M derived: sum of 3 quarters · filed 2026-03-09 | -$4.66M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $4.01M derived: sum of 2 quarters · filed 2025-11-06 | -$5.58M 10-Q · filed 2025-11-06 | -$3.50M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$7.17M 10-Q · filed 2025-08-07 | -$5.09M derived: sum of 3 quarters · filed 2025-11-13 | -$8.89M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-03-31 | -$9.59M 10-Q · filed 2025-05-12 | -$7.51M derived: sum of 2 quarters · filed 2025-11-13 | -$11.31M derived: sum of 3 quarters · filed 2025-11-13 | -$9.76M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2023-12-31 | $2.08M derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | -$1.73M derived: sum of 2 quarters · filed 2025-11-13 | -$166.00K derived: sum of 3 quarters · filed 2025-11-13 | -$2.03M 8-K · filed 2025-11-13 | ||||
| 2023-09-30 | -$3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$2.25M derived: sum of 2 quarters · filed 2024-11-06 | -$4.11M 10-Q · filed 2024-11-06 | -$6.86M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$302.00K 10-Q · filed 2024-08-08 | -$3.06M derived: sum of 3 quarters · filed 2025-03-17 | $10.40M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$1.86M 10-Q · filed 2024-05-09 | -$4.61M derived: sum of 2 quarters · filed 2025-03-17 | $8.84M derived: sum of 3 quarters · filed 2025-03-17 | $2.60M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $10.70M derived: sum of 2 quarters · filed 2025-03-17 | $4.46M derived: sum of 3 quarters · filed 2025-03-17 | $4.21M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | $13.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $7.21M derived: sum of 2 quarters · filed 2023-11-06 | $6.97M 10-Q · filed 2023-11-06 | $255.00K derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | -$6.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$6.49M 10-Q · filed 2023-08-02 | -$13.20M derived: sum of 3 quarters · filed 2024-03-15 | -$7.98M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | -$248.00K 10-Q · filed 2023-05-08 | -$6.96M derived: sum of 2 quarters · filed 2024-03-15 | -$1.74M derived: sum of 3 quarters · filed 2024-03-15 | -$1.97M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | -$6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$1.49M derived: sum of 2 quarters · filed 2024-03-15 | -$1.72M derived: sum of 3 quarters · filed 2024-03-15 | -$3.83M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | $5.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.99M derived: sum of 2 quarters · filed 2022-11-08 | $2.88M 10-Q · filed 2022-11-08 | $385.00K derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | -$226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.33M 10-Q · filed 2022-08-04 | -$4.83M derived: sum of 3 quarters · filed 2023-03-06 | $2.94M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | -$2.11M 10-Q · filed 2022-05-05 | -$4.61M derived: sum of 2 quarters · filed 2023-03-06 | $3.17M derived: sum of 3 quarters · filed 2023-03-06 | $5.64M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $5.27M derived: sum of 2 quarters · filed 2023-03-06 | $7.75M derived: sum of 3 quarters · filed 2023-03-06 | $10.85M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $7.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $10.25M derived: sum of 2 quarters · filed 2021-11-08 | $13.35M 10-Q · filed 2021-11-08 | $16.55M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $5.58M 10-Q · filed 2021-08-05 | $8.77M derived: sum of 3 quarters · filed 2022-02-23 | $7.41M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $3.10M 10-Q · filed 2021-05-06 | $6.30M derived: sum of 2 quarters · filed 2022-02-23 | $4.93M derived: sum of 3 quarters · filed 2022-02-23 | $3.43M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $1.83M derived: sum of 2 quarters · filed 2022-02-23 | $329.00K derived: sum of 3 quarters · filed 2022-02-23 | $672.00K 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$2.87M derived: sum of 2 quarters · filed 2020-11-05 | -$2.52M 10-Q · filed 2020-11-05 | -$4.39M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.16M 10-Q · filed 2020-08-06 | -$3.03M derived: sum of 3 quarters · filed 2021-02-25 | -$3.52M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $343.00K 10-Q · filed 2020-05-07 | -$1.53M derived: sum of 2 quarters · filed 2021-02-25 | -$2.02M derived: sum of 3 quarters · filed 2021-02-25 | -$5.96M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$2.36M derived: sum of 2 quarters · filed 2021-02-25 | -$6.30M derived: sum of 3 quarters · filed 2021-02-25 | -$7.06M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$494.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$4.43M derived: sum of 2 quarters · filed 2019-11-08 | -$5.19M 10-Q · filed 2019-11-08 | -$6.98M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$4.70M 10-Q · filed 2019-08-05 | -$6.49M derived: sum of 3 quarters · filed 2020-02-27 | -$18.94M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$763.00K 10-Q · filed 2019-05-09 | -$2.55M derived: sum of 2 quarters · filed 2020-02-27 | -$15.01M derived: sum of 3 quarters · filed 2020-02-27 | -$9.47M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$14.24M derived: sum of 2 quarters · filed 2020-02-27 | -$8.71M derived: sum of 3 quarters · filed 2020-02-27 | -$7.79M 10-K · filed 2020-02-27 | -$15.96M 10-K · filed 2018-03-08 | |||
| 2017-09-30 | -$12.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$6.92M derived: sum of 2 quarters · filed 2018-11-08 | -$6.00M 10-Q · filed 2018-11-08 | -$10.53M 10-Q · filed 2017-11-06 | $28.23M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $5.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $6.46M 10-Q · filed 2018-08-08 | $2.58M 10-Q · filed 2017-08-07 | $40.69M derived: sum of 3 quarters · filed 2019-02-28 | $42.32M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $923.00K 10-Q · filed 2018-05-10 | -$1.15M 10-Q · filed 2017-05-08 | $35.15M derived: sum of 2 quarters · filed 2019-02-28 | $36.78M derived: sum of 3 quarters · filed 2019-02-28 | $25.82M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $34.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $35.86M derived: sum of 2 quarters · filed 2019-02-28 | $24.89M derived: sum of 3 quarters · filed 2019-02-28 | $16.12M 10-K · filed 2019-02-28 | -$3.13M 10-K · filed 2017-03-14 | |||
| 2016-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$9.34M derived: sum of 2 quarters · filed 2017-11-06 | -$18.11M 10-Q · filed 2017-11-06 | -$15.02M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | -$10.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$19.74M 10-Q · filed 2017-08-07 | -$16.65M derived: sum of 3 quarters · filed 2018-03-08 | -$11.93M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | -$8.78M 10-Q · filed 2017-05-08 | -$5.68M derived: sum of 2 quarters · filed 2018-03-08 | -$958.00K derived: sum of 3 quarters · filed 2018-03-08 | |||||
| 2015-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $7.82M derived: sum of 2 quarters · filed 2018-03-08 | $14.29M 10-K · filed 2018-03-08 | |||||
| 2015-09-30 | $4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $11.19M 10-Q · filed 2016-11-09 | ||||||
| 2015-06-30 | $6.47M 10-Q · filed 2016-08-09 | |||||||
| 2014-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $14.70M derived: sum of 2 quarters · filed 2017-03-14 | $13.24M derived: sum of 3 quarters · filed 2017-03-14 | $14.69M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | $12.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $10.71M derived: sum of 2 quarters · filed 2015-11-10 | $12.16M 10-Q · filed 2015-11-10 | $14.38M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$5.00K 10-Q · filed 2015-08-10 | $2.22M derived: sum of 3 quarters · filed 2016-02-29 | |||||
| 2014-03-31 | $1.45M 10-Q · filed 2015-05-11 | $3.67M derived: sum of 2 quarters · filed 2016-02-29 | ||||||
| 2013-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.28M 10-K · filed 2016-02-29 | ||||||
| 2013-09-30 | $1.06M 10-Q · filed 2014-12-15 | |||||||
| 2012-12-31 | $2.00M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |